Development of alginate-spermidine micro/nanogels as potential antioxidant and anti-inflammatory tool in peripheral nerve injuries. Formulation studies and physico-chemical characterization.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
15 Oct 2022
Historique:
received: 10 03 2022
revised: 29 08 2022
accepted: 30 08 2022
pubmed: 9 9 2022
medline: 30 9 2022
entrez: 8 9 2022
Statut: ppublish

Résumé

The development of a successful strategy to ensure a full recovery in patients affected by peripheral nerve injury (PNI), one of the most debilitating pathologies, is, still today, a major clinical challenge. Herein, spermidine (SP), an endogenous polyamine, is employed with a dual role: as cross-linking agent for alginate (ALG) and as antioxidant and anti-inflammatory compound. In particular, micro/nanogels based on the ionic interaction between ALG and SP were obtained via ionotropic gelation. Different ALG concentrations and viscosity grades and different SP concentrations were considered. The influence of such variables on micro/nanogels size was investigated by means of a Design of Experiments (DoE) approach (full factorial design). The formation of micro/nanogels was proved by Scanning Electron Microscope (SEM) analysis and by rheological and profilometry measurements. Fourier Transform Infrared (FTIR) measurements performed on nanogels of optimal composition confirmed SP-ALG interaction. The addition of trehalose as cryoprotectant agent to nanogel dispersion was considered in view of the employment of freeze-drying process to obtain a stable product. Moreover, in vitro studies on Schwann cells proved the ability of SP of expressing antioxidant and anti-inflammatory properties, even if involved in the formation of nanogels.

Identifiants

pubmed: 36075525
pii: S0378-5173(22)00722-0
doi: 10.1016/j.ijpharm.2022.122168
pii:
doi:

Substances chimiques

Alginates 0
Anti-Inflammatory Agents 0
Antioxidants 0
Nanogels 0
Trehalose B8WCK70T7I
Spermidine U87FK77H25

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122168

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Caterina Valentino (C)

Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy. Electronic address: caterina.valentino01@universitadipavia.it.

Barbara Vigani (B)

Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy. Electronic address: barbara.vigani@unipv.it.

Ilaria Fedeli (I)

Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy. Electronic address: ilaria.fedeli01@universitadipavia.it.

Dalila Miele (D)

Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy. Electronic address: dalila.miele@unipv.it.

Giorgio Marrubini (G)

Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy. Electronic address: giorgio.marrubini@unipv.it.

Lorenzo Malavasi (L)

Department of Chemistry, University of Pavia, Viale Taramelli, 16, 27100 Pavia, Italy. Electronic address: lorenzo.malavasi@unipv.it.

Franca Ferrari (F)

Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy. Electronic address: franca.ferrari@unipv.it.

Giuseppina Sandri (G)

Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy. Electronic address: giuseppina.sandri@unipv.it.

Silvia Rossi (S)

Department of Drug Sciences, University of Pavia, Viale Taramelli, 12, 27100 Pavia, Italy. Electronic address: silvia.rossi@unipv.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH